These observations might be indicative of more severe (degenerative) changes in IBM patients' muscle, potentially driven by KDM5A overactivity, and more specifically, what the sequence of events is leading up to KDM5A overactivity in IBM, that is, whether KDM5A is a true primary driver or triggered by a yet unknown stimulus. The gene discussed is KDM5A; the disease is inclusion body myositis.